GlucoTrack, Inc. (GCTK) Insider Trading Activity

NASDAQ$0.606
Market Cap
$343,878.00
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
577 of 870
Rank in Industry
32 of 43

GCTK Insider Trading Activity

GCTK Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
–
Sells
$0
0
–

Related Transactions

About GlucoTrack, Inc.

GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.

Insider Activity of GlucoTrack, Inc.

Over the last 12 months, insiders at GlucoTrack, Inc. have bought $0 and sold $0 worth of GlucoTrack, Inc. stock.

On average, over the past 5 years, insiders at GlucoTrack, Inc. have bought $230,000 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 182,540 shares for transaction amount of $230,000 was made by SYCOFF DREW () on 2024‑04‑22.

List of Insider Buy and Sell Transactions, GlucoTrack, Inc.

2024-04-22PurchaseSYCOFF DREW
182,539.6
3.6507%
$1.26
$230,000
-69.37%
Total: 1

GCTK Institutional Investors: Active Positions

Increased Positions4+44.44%59,455+944.03%
Decreased Positions3-33.33%1,781-28.28%
New Positions2New59,355New
Sold Out Positions0Sold Out0Sold Out
Total Postitions10+11.11%63,972+915.75%

GCTK Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

No data is available at this moment.

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.